Avera Pharmaceutical
Specialty pharmaceutical company that acquires, develops, and commercializes pharmaceutical compounds.
Launch date
Market cap
-
Enterprise valuation
AUD297—445m (Dealroom.co estimates Aug 2004.)
San Diego California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$20.0m | Series A | ||
$8.0m | Series B | ||
$48.0m | Series C | ||
Total Funding | AUD117m |